Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis

SUMMARY: Janus kinase (JAK) inhibitors are used to treat rheumatoid arthritis (RA). We assessed the effects of tofacitinib on bone density and bone markers in association with clinical and laboratory parameters in RA. Tofacitinib stabilized bone density and resulted in a positive balance of bone tur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamar, A., Szekanecz, Z., Pusztai, A., Czókolyová, M., Végh, E., Pethő, Z., Bodnár, N., Gulyás, K., Horváth, Á., Soós, B., Bodoki, L., Bhattoa, H. P., Nagy, G., Tajti, G., Panyi, G., Szekanecz, É., Domján, A., Hodosi, K., Szántó, S., Szűcs, G., Szamosi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376736/
https://www.ncbi.nlm.nih.gov/pubmed/33559714
http://dx.doi.org/10.1007/s00198-021-05871-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376736/
https://www.ncbi.nlm.nih.gov/pubmed/33559714
http://dx.doi.org/10.1007/s00198-021-05871-0

Ejemplares similares